{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:55:25Z","timestamp":1770472525535,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejps.2013.04.034","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T23:46:44Z","timestamp":1368575204000},"page":"595-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Polymer-free and polyvinylpirrolidone-based electrospun solid dosage forms for drug dissolution enhancement"],"prefix":"10.1016","volume":"49","author":[{"given":"Tam\u00e1s","family":"Vigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00edmea","family":"Horv\u00e1thov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter Lajos","family":"S\u00f3ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Dr\u00e1vav\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsombor Krist\u00f3f","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Marosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.04.034_b0005","doi-asserted-by":"crossref","unstructured":"Aina, A., Hargreaves, M.D., Matousek, P., Burley, J.C., 2010. Transmission Raman spectroscopy as a tool for quantifying polymorphic content of pharmaceutical formulations, Analyst, vol. 135. Cambridge, UK, pp. 2328\u20132333.","DOI":"10.1039\/c0an00352b"},{"key":"10.1016\/j.ejps.2013.04.034_b0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejps.2012.06.009","article-title":"Strategic funding priorities in the pharmaceutical sciences allied to quality by design (QbD) and process analytical technology (PAT)","volume":"47","author":"Aksu","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.034_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jps.22750","article-title":"Supersaturating drug delivery systems: fast is not necessarily good enough","volume":"101","author":"Augustijns","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.034_b0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ejps.2013.04.034_b0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2013.04.034_b0035","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1039\/c0cc01484b","article-title":"Cyclodextrin nanofibers by electrospinning","volume":"46","author":"Celebioglu","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejps.2013.04.034_b0030","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1021\/la1050223","article-title":"Electrospinning of polymer-free nanofibers from cyclodextrin","volume":"27","author":"Celebioglu","year":"2011","journal-title":"Inclusion Complexes Langmuir"},{"key":"10.1016\/j.ejps.2013.04.034_b0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2009.06.014","article-title":"Oral strip technology: overview and future potential","volume":"139","author":"Dixit","year":"2009","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2013.04.034_b0045","unstructured":"European Medicines Agency, Human Medicines Development and Evaluation, 2012. Revised priority list for studies into off-patient paediatric medicinal products. EMA\/98717\/2012. <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2009\/10\/WC500004017.pdf> (13.03.13)."},{"key":"10.1016\/j.ejps.2013.04.034_b0050","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-b-cyclodextrin (HP-b-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2013.04.034_b0055","first-page":"1","article-title":"Mouth dissolving tablets: a novel approach to drug delivery","volume":"3","author":"Kaur","year":"2011","journal-title":"Int. J. Curr. Pharm. Res."},{"key":"10.1016\/j.ejps.2013.04.034_b0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1081\/DDC-52182","article-title":"Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound","volume":"31","author":"Langguth","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(94)90155-4","article-title":"The effect of water-soluble polymers on drug-cyclodextrin complexation","volume":"110","author":"Loftsson","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/00405160902904641","article-title":"Physical principles of electrospinning (electrospinning as a nano-scale technology of the twenty-first century)","volume":"41","author":"Lukas","year":"2009","journal-title":"Text. Prog."},{"key":"10.1016\/j.ejps.2013.04.034_b0080","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1366\/000370206779321463","article-title":"Bulk raman analysis of pharmaceutical tablets","volume":"60","author":"Matousek","year":"2006","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.ejps.2013.04.034_b0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jrs.1688","article-title":"Non-invasive probing of pharmaceutical capsules using transmission Raman spectroscopy","volume":"38","author":"Matousek","year":"2007","journal-title":"J. Raman Spectrosc."},{"key":"10.1016\/j.ejps.2013.04.034_b0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3144\/expresspolymlett.2010.92","article-title":"Electrospun water soluble polymer mat for ultrafast release of Donepezil HCl","volume":"4","author":"Nagy","year":"2010","journal-title":"Express Polym. Lett."},{"key":"10.1016\/j.ejps.2013.04.034_b0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jps.22731","article-title":"Comparison of electrospun and extruded soluplus\u00ae-based solid dosage forms of improved dissolution","volume":"101","author":"Nagy","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.034_b0100","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jps.23374","article-title":"Solvent-free melt electrospinning for preparation of fast dissolving drug delivery system and comparison with solvent-based electrospun and melt extruded systems","volume":"102","author":"Nagy","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.034_b0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10973-010-0936-0","article-title":"Thermal and spectroscopic analysis of inclusion complex of spironolactone prepared by evaporation and hot melt methods","volume":"102","author":"Patyi","year":"2010","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejps.2013.04.034_b0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molstruc.2007.07.043","article-title":"Study of interaction of spironolactone with hydroxypropyl-[beta]-cyclodextrin in aqueous solution and in solid state","volume":"878","author":"Rajabi","year":"2008","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2013.04.034_b0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10856-011-4518-x","article-title":"A simple drug anchoring microfiber scaffold for chondrocyte seeding and proliferation","volume":"23","author":"Rampichov\u00e1","year":"2012","journal-title":"J. Mater. Sci.: Mater. Med."},{"key":"10.1016\/j.ejps.2013.04.034_b0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1248\/cpb.51.734","article-title":"Measurement of diffusion coefficients of parabens and steroids in water and 1-octanol","volume":"51","author":"Seki","year":"2003","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2013.04.034_b0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0734-9750(02)00020-4","article-title":"Biotechnological applications of cyclodextrins","volume":"20","author":"Singh","year":"2002","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejps.2013.04.034_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(96)04862-4","article-title":"Amorphous spironolactone-hydroxypropylated cyclodextrin complexes with superior dissolution and oral bioavailability","volume":"149","author":"Soliman","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3144\/expresspolymlett.2011.34","article-title":"Preparations, properties and applications of chitosan based nanofibers fabricated by electrospinning","volume":"5","author":"Sun","year":"2011","journal-title":"Express Polym. Lett."},{"key":"10.1016\/j.ejps.2013.04.034_b0135","first-page":"431","article-title":"Spironolactone","volume":"vol. 4","author":"Sutter","year":"1975"},{"key":"10.1016\/j.ejps.2013.04.034_b0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejpb.2005.05.006","article-title":"Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins","volume":"61","author":"Szejtli","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-409X(98)00092-1","article-title":"Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development","volume":"36","author":"Szente","year":"1999","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.ejps.2013.04.034_b0150","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejps.2012.08.006","article-title":"Antibacterial fluoroquinolone antibiotic-containing fibrous materials from poly(l-lactide-co-d, l-lactide) prepared by electrospinning","volume":"47","author":"Toncheva","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.04.034_b0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5173(02)00664-6","article-title":"Effect of PVP K-25 on the formation of the naproxen:\u03b2-ciclodextrin complex","volume":"253","author":"Valero","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1023\/A:1023450006281","article-title":"Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning","volume":"20","author":"Verreck","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.04.034_b0165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3109\/1061186X.2010.525652","article-title":"Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility","volume":"18","author":"Warren","year":"2010","journal-title":"J. Drug. Targeting"},{"key":"10.1016\/j.ejps.2013.04.034_b0170","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10856-010-4100-y","article-title":"Ester prodrug-loaded electrospun cellulose acetate fiber mats as transdermal drug delivery systems","volume":"21","author":"Wu","year":"2010","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ejps.2013.04.034_b0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/03639040802302157","article-title":"Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique","volume":"35","author":"Yassin","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2013.04.034_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4236\/health.2009.12012","article-title":"Electrospun nanofiber-based drug delivery systems","volume":"1","author":"Yu","year":"2009","journal-title":"Health"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T20:38:15Z","timestamp":1563050295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098713001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0928098713001826"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.04.034","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymer-free and polyvinylpirrolidone-based electrospun solid dosage forms for drug dissolution enhancement","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2013.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}